Evidence map›Paper›PMID 39578912›Full record

ReviewMolecular neurodegeneration2024

Nuclear pore and nucleocytoplasmic transport impairment in oxidative stress-induced neurodegeneration: relevance to molecular mechanisms in Pathogenesis of Parkinson's and other related neurodegenerative diseases.

Zainab Riaz, Gabriel S Richardson, Huajun Jin, Gary Zenitsky, Vellareddy Anantharam, Arthi Kanthasamy, Anumantha G Kanthasamy

Abstract readReview
In one paragraph

Review in Molecular neurodegeneration, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Nuclear dysfunction in aging and neurodegeneration.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zainab RiazIsakson Center for Neurological Disease Research, Department of Physiology and Pharmacology, University of Georgia, Athens, GA, USA.
Gabriel S RichardsonIsakson Center for Neurological Disease Research, Department of Physiology and Pharmacology, University of Georgia, Athens, GA, USA.
Huajun JinIsakson Center for Neurological Disease Research, Department of Physiology and Pharmacology, University of Georgia, Athens, GA, USA.
Gary ZenitskyIsakson Center for Neurological Disease Research, Department of Physiology and Pharmacology, University of Georgia, Athens, GA, USA.
Vellareddy AnantharamIsakson Center for Neurological Disease Research, Department of Physiology and Pharmacology, University of Georgia, Athens, GA, USA.
Arthi KanthasamyIsakson Center for Neurological Disease Research, Department of Physiology and Pharmacology, University of Georgia, Athens, GA, USA.
Anumantha G KanthasamyIsakson Center for Neurological Disease Research, Department of Physiology and Pharmacology, University of Georgia, Athens, GA, USA. anumantha.kanthasamy@uga.edu.ORCID 0000-0002-6454-4264

Funding

Compensatory Mitochondrial Protective Mechanisms Against Oxidative Stress in PDR01NS121692 · NINDS · UNIVERSITY OF GEORGIA · PI ARTHI KANTHASAMY, Anumantha Gounder Kanthasamy · 2022 to 2026
$2.2M
The Role of KCa3.1 in Microglial function and in Parkinsons disease pathogenesisR01NS124226 · NINDS · UNIVERSITY OF GEORGIA · PI ARTHI KANTHASAMY, HEIKE WULFF · 2021 to 2026
$1.9M
Role of Prokineticin 2 in Metal NeurotoxicityR01ES034196 · NIEHS · UNIVERSITY OF GEORGIA · PI ARTHI KANTHASAMY, Anumantha Gounder Kanthasamy · 2023 to 2026
$1.7M
Novel Mechanisms of Pesticide-Induced NeurotoxicityR01ES027245 · NIEHS · UNIVERSITY OF GEORGIA · PI KANTHASAMY, ANUMANTHA GOUNDER · 2017 to 2021
$1.7M
NIEHS NIH HHS R01 ES027245NIEHS NIH HHS R01 ES034196NIH HHS ES027245NIH HHS ES034196NIH HHS NS121692NIH HHS NS124226NINDS NIH HHS R01 NS121692NINDS NIH HHS R01 NS124226
6 · The paper itself

Abstract

Nuclear pore complexes (NPCs) are embedded in the nuclear envelope and facilitate the exchange of macromolecules between the nucleus and cytoplasm in eukaryotic cells. The dysfunction of the NPC and nuclear transport plays a significant role in aging and the pathogenesis of various neurodegenerative diseases. Common features among these neurodegenerative diseases, including Parkinson's disease (PD), encompass mitochondrial dysfunction, oxidative stress and the accumulation of insoluble protein aggregates in specific brain regions. The susceptibility of dopaminergic neurons to mitochondrial stress underscores the pivotal role of mitochondria in PD progression. Disruptions in mitochondrial-nuclear communication are exacerbated by aging and α-synuclein-induced oxidative stress in PD. The precise mechanisms underlying mitochondrial impairment-induced neurodegeneration in PD are still unclear. Evidence suggests that perturbations in dopaminergic neuronal nuclei are linked to PD-related neurodegeneration. These perturbations involve structural damage to the nuclear envelope and mislocalization of pivotal transcription factors, potentially driven by oxidative stress or α-synuclein pathology. The presence of protein aggregates, pathogenic mutations, and ongoing oxidative stress can exacerbate the dysfunction of NPCs, yet this mechanism remains understudied in the context of oxidative stress-induced PD. This review summarizes the link between mitochondrial dysfunction and dopaminergic neurodegeneration and outlines the current evidence for nuclear envelope and nuclear transport abnormalities in PD, particularly in oxidative stress. We highlight the potential role of nuclear pore and nucleocytoplasmic transport dysfunction in PD and stress the importance of systematically investigating NPC components in PD.

Indexed as

Active Transport, Cell NucleusNeurodegenerative DiseasesNuclear PoreOxidative StressParkinson Diseasealpha-SynucleinAnimalsHumansMitochondriaalpha-SynucleinAlpha-synucleinNeurodegenerationNuclear pore complexNucleocytoplasmic transportOxidative stressParkinson’s disease

Identifiers

PMID39578912
PMCPMC11585115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.